Details of the Drug Formulations

General Information of Drug (ID: DMEBOFW)

• Drug Name: Clofazimine Drug Info
• Synonyms: clofazimine; 2030-63-9; Lamprene; Lampren; Chlofazimine; Clofazimina; Clofaziminum; Clofaziminum [INN-Latin]; B 663 (Pharmaceutical); Clofazimina [INN-Spanish]; B-663; NSC-141046; G 30320; UNII-D959AE5USF; B 663 (VAN); C27H22Cl2N4; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; B 663; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine; EINECS 217-980-2; CFZ; SMP2_000339; B 663, pharmaceutical; G-30320; Lamprene (TN); Liposome-encapsulated clofazimine; Clofazimine [USAN:INN:BAN]; G-30,320; Clofazimine (JAN/USP/INN); N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine; N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine; (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]; Riminophenazine

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Approved	[1]
Leprosy		Approved	[2]
Multibacillary leprosy		Approved	[2]
Pyoderma gangrenosum	EB21	Approved	[2]
Mycobacterium infection	1B10-1B21	Investigative	[3]

• Therapeutic Class: Antiinflammatory Agents
• Cross-matching ID:
  PubChem CID: 2794
  ChEBI ID: CHEBI:3749
  CAS Number: 2030-63-9
  TTD ID: D0S5UH
  VARIDT ID: DR00669
  INTEDE ID: DR0346
  ACDINA ID: D00956

Full List of Drug Formulations Containing This Drug

Clofazimine 100mg capsule

Company	Formulation ID	FDA Description
Novartis	F23118	Beeswax; Butylated Hydroxytoluene; Citric Acid; Ethyl Vanillin; Gelatin; Glycerin; Iron Oxide; Lecithin; P-Methoxy Acetophenone; Parabens; Plant Oils; Propylene Glycol; Ethyl Parahydroxybenzoate Sodium; Propyl Parahydroxybenzoate Sodium; Ethylvanillin; Gelatin; Glycerol; Black Iron Oxide; Red Iron Oxide; P-Methoxy Acetophenone

References

• [1] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019500.
• [2] Clofazimine FDA Label
• [3] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.